Literature DB >> 15170862

Synthesis of immune modulators by smooth muscles.

Cherie A Singer1, Sonemany Salinthone, Kimberly J Baker, William T Gerthoffer.   

Abstract

The primary function of smooth muscle cells is to contract and alter the stiffness or diameter of hollow organs such as blood vessels, the airways and the gastrointestinal and urogenital tracts. In addition to purely structural functions, smooth muscle cells may play important metabolic roles, particularly in various inflammatory responses. In cell culture, these cells have been shown to be metabolically dynamic, synthesizing and secreting extracellular matrix proteins, glycosaminoglycans and a wide variety of cell-cell signaling proteins, such as interleukins, chemokines and peptide growth factors. Secreted cell signaling proteins participate in the inflammatory response of smooth muscle-containing organs, and some can also stimulate smooth muscle migration, proliferation and contraction. The cellular signaling pathways controlling synthesis of these signaling proteins are similar to those used by cells mediating innate immunity and may contribute to pathogenesis of diverse diseases including atherosclerosis, asthma, inflammatory bowel diseases and preterm labor. Appreciating the role of smooth muscle cells in these diseases may lead to better understanding of the beneficial effects of anti-inflammatory drugs as well as identification of new targets for anti-inflammatory therapy. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170862     DOI: 10.1002/bies.20041

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  22 in total

1.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

2.  Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.

Authors:  Min Ding; Ana Catarina Carrão; Robert J Wagner; Yi Xie; Yu Jin; Eva M Rzucidlo; Jun Yu; Wei Li; George Tellides; John Hwa; Tamar R Aprahamian; Kathleen A Martin
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

3.  Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis.

Authors:  Yonggang Zhang; Fang Li; Hong Wang; Chaoran Yin; JieAn Huang; Sunila Mahavadi; Karnam S Murthy; Wenhui Hu
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

Review 4.  Small heat shock proteins in smooth muscle.

Authors:  Sonemany Salinthone; Manoj Tyagi; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

5.  Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis.

Authors:  Allison B Herman; Milessa Silva Afonso; Sheri E Kelemen; Mitali Ray; Christine N Vrakas; Amy C Burke; Rosario G Scalia; Kathryn Moore; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

6.  Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.

Authors:  Khatuna Gabunia; Surbhi Jain; Ross N England; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

7.  Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet.

Authors:  Laura J Sommerville; Sheri E Kelemen; Stephen P Ellison; Ross N England; Michael V Autieri
Journal:  Atherosclerosis       Date:  2011-08-06       Impact factor: 5.162

8.  Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.

Authors:  Ying Tian; Laura J Sommerville; Anthony Cuneo; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

Review 9.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

10.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.

Authors:  Wenhui Hu; Sunila Mahavadi; Fang Li; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-24       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.